Gisler, S. (2022). Sifting through the regulatory weeds: How to use diverse genetic screening strategies to enhance cancer research and drug development. [Thesis, fully internal, Universiteit van Amsterdam].
Koppens, M. A. J. (2017). Guardians of cell identity: Functional analysis of PRC2 proteins in intestinal homeostasis and cancer. [Thesis, externally prepared, Universiteit van Amsterdam].
Ellenbroek, S. I. J. (2013). The function of Tiam1/Rac signaling in polarity and cancer. [Thesis, fully internal, Universiteit van Amsterdam].
Peuscher, M. H. (2013). Identification of novel factors controlling DNA damage responses at uncapped telomeres. [Thesis, fully internal, Universiteit van Amsterdam].
Sachs, L. N. (2013). The role of CD151 and integrin α3β1 in the pathophysiology of kidney and skin. [Thesis, fully internal, Universiteit van Amsterdam].
Hogenbirk, M. A. (2013). Defining risk factors for genomic instability in B cells: Novel insights from NGS-based technologies. [Thesis, externally prepared, Universiteit van Amsterdam].
Margadant, C. (2013). Regulation of integrin function and trafficking. [Thesis, fully internal, Universiteit van Amsterdam].
Frijns, E. J. E. (2012). Controling hemidesmosome dynamics by phosphorylation of the integrin β4 subunit. [Thesis, fully internal, Universiteit van Amsterdam].
Drost, R. M. (2012). Stepping into the RING: preclinical models in the fight against hereditary breast cancer. [Thesis, fully internal, Universiteit van Amsterdam]. Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis.
Ketema, M. (2012). Nesprin-3 as a LINC between the nucleus and intermediate filaments. [Thesis, fully internal, Universiteit van Amsterdam].
